Kapil Kothary

Kapil Kothary is a seasoned bio-pharma leader and consultant with expertise in gene therapy, viral vectors, and the manufacturing of monoclonal antibodies, vaccines, and plasma proteins. They have held significant roles, including Associate Director at Merck from 2016 to 2020 and Director of Manufacturing Sciences and Technology at CSL Behring since 2020. Kapil's experience encompasses process development, technology transfer, and CMC commercialization activities across multiple organizations, including Genentech and Teva Pharmaceuticals. Their knowledge spans late-stage process optimization and facility design in the biopharmaceutical industry.